This face mask can detect kidney disease with just your breath
Published in ACS Sensors, the study showed that the smart mask uses a tiny sensor placed between its layers to detect small molecules in a person's breath. These molecules, called metabolites, are linked to chronic kidney disease. In early tests, the mask was able to identify people with the disease with high accuracy.
The smart mask uses a tiny sensor placed between its layers to detect small molecules in a person's breath. (Photo: ACS Sensors)
Kidney patients are known to exhale more ammonia than healthy individuals. But ammonia can also appear in other illnesses. So, researchers led by Corrado Di Natale, an Italy-based electrical engineer, wanted to create a sensor that could detect ammonia along with other chemicals linked specifically to chronic kidney disease.advertisementTo do this, they coated tiny silver electrodes with a polymer commonly used in chemical sensors. This polymer was further enhanced with porphyrins, molecules that react with gases in breath.These coated electrodes were then added to the mask and connected to a small electronic reader.When someone wearing the mask breathes out, the gases interact with the sensor. This causes changes in electrical resistance, which helps detect chemicals like ammonia, ethanol, propanol and aceton, all linked to chronic kidney disease.
The smart mask can detect metabolites in the breath to reveal information about kidney disease. (Photo: ACS Sensor)
The team tested the sensor on 100 people, half with the kidney disease and half without. The mask correctly identified chronic kidney disease in 84% of the cases and correctly ruled it out in 88% of people who were healthy. It also showed promise in estimating the stage of chronic kidney disease.According to the researchers, this kind of breath-based, wearable sensor could make diagnosing and monitoring kidney disease easier, faster and more affordable.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
8 minutes ago
- Mint
Coldplay's Chris Martin jokes after Andy Byron, HR chief, caught on kiss cam: ‘Hope we didn't do something bad'
Coldplay frontman Chris Martin sparked laughter across the stadium on Wednesday after a kiss cam unexpectedly exposed Andy Byron, CEO of the New York-based AI firm Astronomer, and the company's HR head, Kristin Cabot, who appeared visibly mortified after being shown cuddling on the jumbotron. 'Holy sh—t!' Chris Martin exclaimed after spotting the couple on the jumbotron. 'I hope we didn't do something bad,' he added with a chuckle, as Andy Byron and Kristin Cabot quickly moved out of frame, clearly flustered. 'Either they're having an affair or they're just very shy,' he added. Kristin Cabot, his apparent companion at the show, serves as Astronomer's Chief People Officer, a role where she proudly claims to build "trust with employees of all levels." The company's headquarters, coincidentally, lie just hours from the concert venue in Foxborough, Massachusetts. According to his LinkedIn profile, Andy Byron has been serving as the chief executive officer of Astronomer since July 2023. Public records indicate that Byron and his wife, Megan Kerrigan — both 50 — live in nearby Northborough and have two children together. Before joining Astronomer, Byron was with Lacework, first as president from June 2019 until November 2022, and then as an advisor until May 2023. Between 2017 and 2019, he served as chief revenue officer at Cybereason. He has also held the roles of president and chief operating officer at Fuze and has previously been associated with Vericenter and BMC Software.
Time of India
an hour ago
- Time of India
Elusive warbler spotted in Ladakh after 46-year gap
Elusive warbler At an elevation of 3,200 metres, Ladakh's rugged mountain sweep in the backdrop, a group of five sat huddled and listened intently to the 'click-clickclick' captured in a recording. The insect-like call was proof that one of the most elusive bird species they had come looking for was there. Visual proof came soon enough, making July 15 the day when a confirmed sighting of the long-billed bush warbler would be recorded after 46 years, in a thicket in Kargil's Suru Valley. The last time the bird (Locustella Major) was seen was also in Ladakh in 1979, when a group of birders from Southampton University were on a tour (1977-80) to chronicle avian fauna. Between 1979 and now, one more sighting of the longbilled bush warbler was documented when ornithologist James Eaton spotted it in Naltar Valley of GilgitBaltistan in 2023. The current expedition by five birders – Harish Thangaraj, Lt Gen Bhupesh Goyal, Manjula Desai, Rigzin Nubu and Irfan Jeelani — was planned specifically to spot this warbler. Team leader Thangaraj told TOI the group 'has years and years of experience sighting birds' and 'what we are now looking for are 'lost birds' – that were spotted decades ago but were never seen since'. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo This Feb, the group had made another expedition in search of the bird but failed to spot it. 'We searched in Gurez and Tulail valleys at altitudes between 2,400m and 2,800m. But it yielded no results, possibly because of altitude mismatch,' Thangaraj said, referring to the Gilgit-Baltistan sighting, which was at a higher reach. After the unsuccessful attempt, the group stepped up research and got in touch with Eaton. It was the Malaysia-based American ornithologist who steered them on the right path – in this case, near terraced fields surrounded by rumex and gooseberry shrubs at Sankoo in Suru. 'The bird was found in a willow amidst terraced fields. It's the first time it has been seen on a willow, which will now be added to its known habitats,' Thangaraj told TOI . At 3,200 metres, this is also the highest recorded altitude at which the bird has been seen. Classified as 'near threatened' by International Union for Conservation of Nature, long-billed bush warblers were commonly seen in Ladakh and GilgitBaltistan till the 1930s. In the decades since, birding expeditions were sparse. In 2015, Eaton wrote, birder Shashank Dalvi sighted two warblers in Suru, but it was too brief for him to take a picture. 'Expansion of settlements combined with climate change, could be pushing the birds to go higher,' Thangaraj said. Pankaj Gupta, a Delhi Bird Society member who was not part of the expedition, said the 'rediscovery' of the bird is 'nothing short of extraordinary'. 'It reminds us how much remains hidden in our fragmented landscapes, and how urgent it is to protect these last remaining pockets of wilderness,' Gupta said.
Mint
2 hours ago
- Mint
India has seen an explosion of fertility startups. Next up: deal spree
Bengaluru/Mumbai: India's growing incomes and falling fertility rate have birthed a new breed of startups looking to fill gaps and provide convenience in assisted reproduction services, drawing interest from investors and large healthcare chains. Upstarts such as Luma Fertility and Arva Health offer services ranging from at-home hormone monitoring and assessment to in-vitro fertilization (IVF) at their centres, while Initomakes portable fertility tracking least 37 fertility ventures were founded between 2021 and 2025 in India, raising $86.4 million combined in equity investments, according to Tracxn data. 'What is interesting is that these startups are highly focused on offering services such as fertility testing and egg freezing, apart from conventional fertility offerings…," said Shobhit Agarwal, chief executive officer at Nova IVF Fertility. 'They are well exposed to European markets, understand the changing landscape of the fertility market in India and are helping to bring new allied services to India and create these markets in larger cities." IVF and other fertility solutions have been available in India for decades. Yet demand has grown in recent years as more women decide to have children later and infertility increases. Rising incomes mean a higher number of Indians can access treatment. EY estimates the nation's IVF market to rise from $793 million in 2020 to $1.45 billion by 2027, expanding 15-20% annually. Mumbai-based Luma offers embryo grading, advanced egg quality assessment, egg freezing, IVF, male and female fertility testing and care and a smartphone application to track hormones and record symptoms. Arva provides everything from hormone testing and fertility consultation to IVF and IUI (intra-uterine insemination). Inito sells at-home single-use kits for monitoring hormone levels during fertility cycles–crucial information for couples struggling to conceive. 'Their (new startups') presence has helped expand awareness and convenience, especially for individuals taking early steps toward understanding their reproductive health," said Kshitiz Murdia, chief executive officer and whole-time director of Indira IVF, the country's largest infertility treatment chain. Private investors are taking notice. Last week, Luma, which recently opened a fertility clinic in Mumbai, announced its $4 million fundraise from Peak XV's Surge, Metropolis Healthcare's promoter Ameera Shah and Vijay Taparia of B2V Ventures. In May, Bengaluru-based Arva secured $1 million in pre-seed funding led by early-stage investment firm All In Capital. Expansion plans Inito plans to enter 20 countries, including Australia and Canada, by next year, founder and chief executive officer Aayush Rai told Mint. 'We're a deeptech company, and the idea is to build a global company. The consumption patterns are different in India and outside, with Western countries more open to adopting newer technologies." Inito lastraised $6 million in Series A funding led by Fireside Ventures in November 2023. Luma Fertility, which recently established its first clinic in Mumbai's Bandra area, is looking to launch two more centres in the financial capital, followed by expansion into Bengaluru, Hyderabad, Pune and Gurugram. 'While a majority of it will be organic expansion, we are open to acquisitions to widen the scope of fertility services like in vitro-fertilization (IVF) and egg freezing,"said Neha Motwani, founder of Luma. There are other startups proving support services . BabyReady provides teleconsultation and financial services for couples seeking fertility treatments and Elawoman offers counselling and access to fertility clinics. India IVF, a chain of tech-enabled fertility care centres across India, received pre-Series A funding last year. Veera Health provides treatment for polycystic ovary syndrome or PCOS, which is known to cause infertility–the venture is backed by Y Combinator and Peak XV's Surge. "My sense is that less than a third of the market is truly organized, chained and branded. The remaining is mostly single-doctor or single-clinic practices," saidArjun Anand, managing director and head of Asia at global investment company Verlinvest. 'Startups that bring a positive differentiation to existing services of IVF & IUI will have an edge." Acquisition targets Verlinvest acquired a controlling stake in AP/Telangana-focused Ferty9 Fertility Centre in 2023. Large chains, too, are watching these startups as potential acquisition targets. Startups play a crucial role in bringing about innovative services that large players cannot possibly introduce at scale, making consolidation a favourable outcome. '...we are not only seeing much intense competition from large chains, but also seeing many new startups in this space," said Agarwal of Nova IVF, which was acquired by Asia Healthcare Holdings in 2019. The chain has 100 centres across the country, with over half of those in tier 2 and 3 cities, including Bareilly, Guwahati, and Vellore. Nova IVF is assessing acquisition opportunities in markets with low presence, said Agarwal. Last month, Economic Times reported, citing unnamed people, that US-based IVI RMA Global is set to acquire ART Fertility Clinics for $400-450 million. Indira IVF inked deals with Gujarat-based Banker Healthcare and Puducherry's Creation Science IVF in June as well. Birla Fertility & IVF acquired BabyScience IVF Clinics to expand its presence in southern and western India last year. Funding in the segment will continue to be driven by private equity investments, according to Verlinvest's Anand. 'Private equity brings scale, while venture capital fosters innovation. IVF is more suited to a private equity play as it's a centre-by-centre model and will take a linear curve to scale." Looking ahead On their part, the startups also continue to evolve to stay relevant. Luma Fertility is offering a more open and detailed analysis of diagnostic reports to its patients, besides investing in establishing a dedicated care team to guide them along the journey. 'For instance, our analysis of an AMH report states X-axis age, Y-axis AMH, where you are compared to the India average, and what this means for you, and what is your predictive decline," said CEO Motwani. 'The first place where the system is broken is how fertility assessment and testing are done. It needs to be more accessible, open, and with less judgment." Inito intends to be a pure-play product company, according to founder Rai. 'There is definite value in building hardware because at-home testing is largely under-penetrated. This segment can grow significantly, potentially outperforming top players in the product side." The startup also plans to foray into men's fertility with specialized products, which Rai termed an underrated topic. Nova IVF's Agarwal sees more opportunities including AI-driven embryo evaluation, genetic testing, newer therapies such as ovarian rejuvenation. "Any addition like a digital-first approach, more efficient tracking capabilities, and new technology will be valuable," saidVerlinvest's Anand. 'Better customer experience, the ability to cater to a premium audience, or a concierge service will help set a startup apart from traditional players." According to Bhanu Prakash Kalmath S J, partner and healthcare industry leader at Grant Thornton Bharat, 'what also matters is how you bring credibility through a better brand". This is what works for larger chains, which offer consistency and uniform services across centres, and that could work for new players as well, he said. Luma and Inito plan to carefully invest in expansion to maintain differentiation and sustainable economics. But Kalmath S.J. suggested that investing in technology to ensure compliance with regulations and complete data confidentiality is paramount too. More so, when big fertility treatment chains also look to protect their turf and stay ahead of the curve. As Sriram Iyer, CEO of Apollo Health and Lifestyle, which runs Apollo Fertility, explained: 'To stay competitive, investment in technology, prioritizing ethical practices, and addressing accessibility challenges are utmost."
